Trial Profile
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2019
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 19 Mar 2019 According to an Endo International media release, Dr. Neil Sadick is a lead investigator.
- 19 Mar 2019 According to an Endo International media release, the data from this trial published in Dermatologic Surgery, the official journal of the American Society for Dermatologic Surgery 2019.
- 19 Mar 2019 Results published in the Endo International Media Release